Poseida Therapeutics, Inc. Deferred Costs, Noncurrent
Poseida Therapeutics, Inc. had Deferred Costs, Noncurrent of $1.88 million as of 2020-06-30, per its 10-Q filed 2020-08-20.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2020-08-20
- 2020-06-30: Deferred Costs, Noncurrent $1.88M.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2020-06-30 | $1.88M 10-Q · filed 2020-08-20 |